Horst-Dietmar Tauschel

Title: The Innovations of Horst-Dietmar Tauschel

Introduction

Horst-Dietmar Tauschel is a notable inventor based in Ettenheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of thrombotic conditions. With a total of two patents to his name, Tauschel's work has had a meaningful impact on medical science.

Latest Patents

Tauschel's latest patents include the use of 1,6-naphthyridinone derivatives in treating pulmonary thrombosis. These new derivatives are described by a specific formula, where R¹ represents an unsubstituted or substituted aromatic or heteroaromatic ring. Additionally, he has developed 2-alkylthio-1-aminoalkyl-2-pyrroline-3-carbonitriles, which are compositions and pharmaceutically acceptable acid addition salts. These compounds are useful for the prophylaxis and therapy of thrombotic states, demonstrating their potential as thrombocyte aggregation inhibitors.

Career Highlights

Throughout his career, Tauschel has worked with prominent companies such as Godecke Aktiengesellschaft and Warner-Lambert Company. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Tauschel has collaborated with notable colleagues, including Gerhard Satzinger and Johannes Hartenstein. These partnerships have likely enriched his research and development efforts.

Conclusion

Horst-Dietmar Tauschel's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of thrombotic conditions.